As the Covid-19 pandemic continues its unprecedented impact on economies around the world, the MedTech industry presses on with product innovation and plans for the future. SmartTRAK reports daily on the challenges still ahead, covering all aspects of the OrthoBio market.

The following is just a small sampling of recent OrthoBio updates from around the world compiled, reviewed and posted in real time by our SmartTRAK analysts. We constantly monitor the worldwide MedTech industry, sifting through the noise to present to our subscribers the most relevant international news, patents, trends, new products, financial data and competitor developments in the global Life Sciences industry.

As part of SmartTRAK's R&D appreciation month, Research & Development professionals can now sign up for a Complimentary Month of Daily Updates delivered straight to your inbox. Just let us show you SmartTRAK and we'll give you a month of Daily Updates, delivered to your inbox, for FREE!

The recovery in breast and hernia procedure stalled in Q420, with revenue dropping -9.2% YoY, according to BioMedGPS’ SmartTRAK Financial Dashboard. AbbVie* maintained its lead despite the effects of the pandemic, off -8.4% YoY, as its breast matrices continued to lag in the overall recovery. Becton Dickinson* (BD) slid –1.2% YoY as hernia procedures bounced back to normal levels a little faster ...

Among the many topics covered in the comprehensive Q420/FY20 US Surgical Matrices Market Recap* are:

SmartTRAK’s consulting business is growing and we need experienced professionals to grow with us! We're looking for subject matter experts with 10+ years of relevant industry experience and expertise in the following areas:

Dr. Wasik Ashraf, an Orthopaedic Surgeon specializing in Sports Medicine, discusses trends and innovation in Orthobiologics and Regenerative Medicine in an interview with SmartTRAK.

In this wide-ranging interview, Dr. Ashraf gives his view of CMS' FY21 OPPS-ASC Final Rulemaking, and discusses emerging trends and innovation in OrthoBiologics and Regenerative Medicine. As a Board-certified and fellowship-trained physician specializing in sports medicine, joint preservation and cartilage restoration, Dr. Ashraf offers his unique view and perspective on some of the newest technologies he is using, as well as those to look out for in the coming years. 

To listen to the interview, recorded live via Uberconference, click on the following video (41:37 min). A transcript of the interview is also available below.

Despite the continuing challenges posed by the pandemic, the MedTech industry presses on with product innovation and plans for the future. SmartTRAK reports daily on the challenges still ahead, covering all aspects of the Neuromodulation market.

The following is just a small sampling of recent Neuromodulation updates from around the world compiled, reviewed and posted in real time by our SmartTRAK analysts. We constantly monitor the worldwide MedTech industry, sifting through the noise to present to our subscribers the most relevant international news, patents, trends, new products, financial data and competitor developments in the global Life Sciences industry.

As part of SmartTRAK's R&D appreciation month, Research & Development professionals can now sign up for a Complimentary Month of Daily Updates delivered straight to your inbox. Just let us show you SmartTRAK and we'll give you a month of Daily Updates for FREE!

The US market for Hemostats and Sealants continued back toward its pre-pandemic levels, gaining +20.0% QoQ and up +1.1% YoY. For FY20, the market declined, as COVID-19 delayed procedures in Q220 proved too much to overcome.

As the US Healthcare system learned to navigate the new normal and elective procedures continued their return toward COVID-19 levels, the US Hemostats and Sealants market finally exceeded pre-pandemic levels, up +1.1% YoY according to SmartTRAK Financial Dashboard. However, for the year the market was down as Q220’s delayed procedures proved too much to overcome.

Among the many topics covered in the comprehensive Q420/FY20 US Hemostats and Sealants Market Recap* are:

Nilesh Patel, MD, vice president of medical affairs for Boston Scientific, discusses the Company’s latest research and innovation in neuromodulation in an interview with SmartTRAK.

With the US launch of the WaveWriter Alpha portfolio of spinal cord stimulation systems, fast-acting sub-perception therapy (FAST) and the Cognita suite of digital solutions, Boston Scientific is expanding the boundaries of pain therapy and fueling a new era of personalization using advanced analytics to identify, predict and intervene early in a patient’s pain. Nilesh Patel, MD, vice president of medical affairs at Boston Scientific (BSX), discusses these advances and more from the virtual NANS 2021 meeting in an interview with SmartTRAK.

To listen to the interview, recorded live via Uberconference, click on the following video. Read on to find out how to receive a transcript of the complete interview.

Facing the prevailing headwinds of the pandemic, the MedTech industry presses on with product innovation and plans for the future. SmartTRAK reports daily on the challenges still ahead, covering all aspects of the Wound Care market, including Advanced Wound Care, Conventional Wound Care, Infection Prevention, Biosurgery, Surgical Matrices, EU and ROW Advanced Dressings and EU Negative Pressure Wound Therapy.

The following is just a small sampling of the Wound Care updates from around the world compiled, reviewed and posted in real time last week by our SmartTRAK analysts. We constantly monitor the worldwide MedTech industry, sifting through the noise to present to our subscribers the most relevant international news, patents, trends, new products, financial data and competitor developments in the global Life Sciences industry.

As part of SmartTRAK's R&D appreciation month, Research & Development professionals can now sign up for a Complimentary Month of Daily Updates delivered straight to your inbox. Just let us show you SmartTRAK and we'll give you a month of Daily Updates for FREE!

Patents:

• Medtronic*
  Medtronic’s US Patent Application “POWERED SURGICAL TACK APPLIER” was published, describing a powered system for surgical tack application for hernia repair. 20210045740

Tracking which procedures will drive growth within the Spine hardware market as we ride the ups and downs of COVID-19.

Following a Q320 rebound in elective procedures sparking a return to growth for the COVID-ravaged Spine market, the recent COVID resurgence has once again dragged US Spine growth rates down. While many companies have yet to report Q420 earnings, early signs point to a downturn, with procedure volumes impacted by hospital resource utilization and renewed restrictions around elective procedures.

In this article, Julianne Burns, SmartTRAK's GM, Spine, looks at the following topics:

• The COVID Impact Update
• Shifts in Cervical Total Disc Replacement (cTDR)
• Growth in Prone Lateral Procedures
• Expansion in SI Joint Fusion
• Innovation in Interbody Materials

Charlie Covert, Medtronic’s VP/GM of Pain Therapies, discusses the Company’s neuromodulation news at NANS 2021 in an interview with SmartTRAK.

To find out about what was new for MDT at NANS 2021, including the 12-month results from MDT’s DTM SCS study, its initiatives in evoked compound action potentials (ECAPs), the Vanta recharge-free SCS and MDT’s research into expanded indications, click on the following video below to listen to SmartTRAK’s interview with Charlie Covert recorded live via Uberconference (25:39 min). A complete transcript of the interview is also provided below.